A new study of more than 400,000 people has found that taking cholesterol-lowering statins does not curb the user's risk of developing colorectal cancer. Previous laboratory studies have found a link between the use of statins such as Lipitor, Crestor, and Zocor and reduced cancer risk, but researchers have been unable to confirm this finding in human clinical trials.
Read full story >